IDO and outcomes in ovarian cancer.

Authors :: Nelson BH
Source :: Gynecologic oncology [Gynecol Oncol] 2009 Nov; Vol. 115 (2), pp. 179-80.
Publication Year :: 2009

Subjects :: Antineoplastic Combined Chemotherapy Protocols pharmacology
CD8-Positive T-Lymphocytes immunology
Drug Synergism
Female
Humans
Indoleamine-Pyrrole 2,3,-Dioxygenase antagonists & inhibitors
Indoleamine-Pyrrole 2,3,-Dioxygenase immunology
Lymphocytes, Tumor-Infiltrating immunology
Ovarian Neoplasms drug therapy
Ovarian Neoplasms immunology
Paclitaxel administration & dosage
Paclitaxel pharmacology
Prognosis
Tryptophan administration & dosage
Tryptophan analogs & derivatives
Tryptophan pharmacology
Indoleamine-Pyrrole 2,3,-Dioxygenase biosynthesis
Ovarian Neoplasms enzymology

Full Text Access

Tools